Corporate Controller – Soleno

Developing novel therapeutics for the treatment of rare diseases.

Pages

News and Events

Soleno Therapeutics Announces Updated Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome

Soleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Contact Us

  • 203 Redwood Shores Parkway
  • Suite 500
  • Redwood City, CA 94065